Madeline Li
Associate Professor of Psychiatry and Clinician Scientist
Data updated
Research Footprint
Madeline Li appears in 5 tracked papers (2018–2026), most studied alongside Ketamine, across Depressive Disorders, Anxiety Disorders and Healthy Volunteers.
Most-cited paper: Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression (179 citations).
Frequent co-authors: Roger McIntyre, Jonathan Rosenblat and Zoe Doyle.
Background & Research
Madeline Li is an associate professor in the Department of Psychiatry at University Health Network and a clinician scientist in the Department of Psychosocial Oncology and Palliative Care at Princess Margaret Cancer Centre. Her work focuses on cancer-related depression, existential distress, palliative care, and the clinical use of ketamine in these settings. She is listed as an author on the 2026 intranasal ketamine study for existential distress in advanced cancer and has also coauthored prior ketamine and supportive-care publications.
Key Impact
She is a notable psycho-oncology and palliative care researcher with multiple ketamine studies in cancer and mood disorders.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →